If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Masaya Kai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Triple Negative Breast Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 290 Citations
  • 9 h-Index
  • 20 Article

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer

Mori, H., Kubo, M., Kai, M., Yamada, M., Kurata, K., Kawaji, H., Kaneshiro, K., Osako, T., Nishimura, R., Arima, N., Okido, M., Kishimoto, J., Oda, Y. & Nakamura, M., Aug 15 2019, In : Breast Cancer Research and Treatment. 176, 3, p. 569-577 9 p.

Research output: Contribution to journalArticle

Open Access
Triple Negative Breast Neoplasms
Lymphocytes
Survival
Tumor-Infiltrating Lymphocytes
Neoplasms

BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations

Mori, H., Kubo, M., Kai, M., Velasquez, V. V., Kurata, K., Yamada, M., Okido, M., Kuroki, S., Oda, Y. & Nakamura, M., Oct 1 2018, In : Clinical Breast Cancer. 18, 5, p. e1217-e1227

Research output: Contribution to journalArticle

Breast Neoplasms
Mutation
Neoplasms
Survival
Triple Negative Breast Neoplasms
1 Citation (Scopus)

Catumaxomab with activated T-cells efficiently lyses chemoresistant EpCAM-positive triple-negative breast cancer cell lines

Kubo, M., Umebayashi, M., Kurata, K., Mori, H., Kai, M., Ohnishi, H., Katano, M., Nakamura, M. & Morisaki, T., Jul 1 2018, In : Anticancer Research. 38, 7, p. 4273-4279 7 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
T-Lymphocytes
Cell Line
Breast Neoplasms
Bispecific Antibodies
4 Citations (Scopus)

Dual mTOR kinase inhibitor MLN0128 sensitize HR þ /HER2 þ breast cancer patient-Derived xenografts to trastuzumab or fulvestrant

Hsu, P. Y., Wu, V. S., Kanaya, N., Petrossian, K., Hsu, H. K., Nguyen, D., Schmolze, D., Kai, M., Liu, C. Y., Lu, H., Chu, P., Vito, C. A., Kruper, L., Mortimer, J. & Chen, S., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 395-406 12 p.

Research output: Contribution to journalArticle

Sirolimus
Heterografts
Phosphotransferases
Breast Neoplasms
Neoplasms

Efficacy and safety of bi-weekly pegfilgrastim for dose-dense chemotherapy-induced neutropenia in breast cancer patients

Mori, H., Kubo, M., Kai, M., Kurata, K., Yamada, M. & Nakamura, M., Jul 1 2018, In : Anticancer research. 38, 7, p. 4381-4386 6 p.

Research output: Contribution to journalArticle

Neutropenia
Cyclophosphamide
Granulocyte Colony-Stimulating Factor
Doxorubicin
Breast Neoplasms